Takeda completes US restructuring after TAP buyout
This article was originally published in Scrip
Executive Summary
Takedahas now completed the consolidation of its US operations following the breakup in March of its TAP Pharmaceutical Productsjoint venture withAbbott, creating an organisation which the Japanese firm says is among the top 15 pharma companies in the US.